en · de · es · fr · pt
cardarine-notes.peptides6088.com › News › Background And Regulatory Status — Practical Notes

Background And Regulatory Status — Practical Notes

By Editorial Desk · published 2025-07-05 · last reviewed 2025-07-26 · News

The short version of anti-doping fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-07-26 and is reviewed periodically as new material appears.

Background and Regulatory Status

Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.

Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.

Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.

Preclinical Findings and Safety Signals

Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.

Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.

Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.

Cardarine at a glance

PropertyValueNotes
IUPAC name{4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acidSystematic name for GW501516
CAS Registry Number317318-70-0Unique identifier for the parent compound
Molecular formulaC21H18F3NO3S2Includes carbon, hydrogen, fluorine, nitrogen, oxygen, and sulfur
Molecular weight453.5 g/molApproximate value for the neutral form
AppearanceWhite to off-white powderTypical description for purified laboratory material

Regulation and Detection

Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.

Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.

Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.

Related pages on this site

Cardarine Identity and Mechanism

Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.

At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.

Mechanism and Detection

Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.

Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.

Further detail

=== Dental syringes === A dental syringe is used by dentists for the injection of an anesthetic. It consists of a breech-loading syringe fitted with a sealed cartridge containing an anesthetic solution. In 1928, Bayer Dental developed, coined and produced a sealed cartridge system under the registered trademark Carpule®. The current trademark owner is Kulzer Dental GmbH. The carpules have long been reserved for anesthetic products for dental use. It is practically a bottomless flask. The latter is replaced by an elastomer plug that can slide in the body of the cartridge. This plug will be pushed by the plunger of the syringe. The neck is closed with a rubber cap. The dentist places the cartridge directly into a stainless steel syringe, with a double-pointed (single-use) needle. The tip placed on the cartridge side punctures the capsule and the piston will push the product. There is therefore no contact between the product and the ambient air during use. The ancillary tool (generally part of a dental engine) used to supply water, compressed air or mist (formed by combination of water and compressed air) to the oral cavity for the purpose of irrigation (cleaning debris away from the area the dentist is working on), is also referred to as a dental syringe or a dental irrigation nozzle. A 3-way syringe/nozzle has separate internal channels supplying air, water or a mist created by combining the pressurized air with the waterflow. The syringe tip can be separated from the main body and replaced when necessary.

=== Menkes disease === Menkes disease, a genetic condition of copper deficiency, was first described by John Menkes in 1962. It is a rare X-linked disorder that affects approximately 1/200,000 live births, primarily boys. Livers of Menkes disease patients cannot absorb essential copper needed for patients to survive. Death usually occurs in early childhood: most affected individuals die before the age of 10 years, although several patients have survived into their teens and early 20s. The protein produced by the Menkes gene is responsible for transporting copper across the gastrointestinal tract (GIT) mucosa and the blood–brain barrier. Mutational defects in the gene encoding the copper ATPase cause copper to remain trapped in the lining of the small intestine. Hence, copper cannot be pumped out of the intestinal cells and into the blood for transport to the liver and consequently to rest of the body. The disease therefore resembles a severe nutritional copper deficiency despite adequate ingestion of copper. Symptoms of the disease include coarse, brittle, depigmented hair and other neonatal problems, including the inability to control body temperature, intellectual disability, skeletal defects, and abnormal connective tissue growth. Menkes patients exhibit severe neurological abnormalities, apparently due to the lack of several copper-dependent enzymes required for brain development, including reduced cytochrome c oxidase activity. The brittle, kinky hypopigmented hair of steely appearance is due to a deficiency in an unidentified cuproenzyme.

On 26 September 1983, Stanislav Petrov, a lieutenant colonel in the Soviet Air Defense Forces, was the officer on duty at the Serpukhov-15 bunker near Moscow which housed the command center of the Soviet early warning satellites, code-named Oko. Petrov's responsibilities included observing the satellite early-warning network and notifying his superiors of any impending nuclear missile attack against the Soviet Union. If notification was received from the early-warning systems that inbound missiles had been detected, the Soviet Union's strategy was an immediate and compulsory nuclear counter-attack against the United States (launch on warning), specified in the doctrine of mutual assured destruction. Shortly after midnight, the bunker's computers reported that one intercontinental ballistic missile was heading toward the Soviet Union from the United States. Petrov considered the detection a computer error, since a first-strike nuclear attack by the United States was likely to involve hundreds of simultaneous missile launches in order to disable any Soviet means of a counterattack. Furthermore, the satellite system's reliability had been questioned in the past. Petrov dismissed the warning as a false alarm, though accounts of the event differ as to whether he notified his superiors or not after he concluded that the computer detections were false and that no missile had been launched. Petrov's suspicion that the warning system was malfunctioning was confirmed when no missile arrived.

Sources: en.wikipedia.org

Background from the literature

Copper chaperone for superoxide dismutase is a metalloprotein that is responsible for the delivery of Cu to superoxide dismutase (SOD1). CCS is a 54kDa protein that is present in mammals and most eukaryotes including yeast. The structure of CCS is composed of three distinct domains that are necessary for its function. Although CCS is important for many organisms, there are CCS independent pathways for SOD1, and many species lack CCS all together, such as C. elegans. In humans the protein is encoded by the CCS gene.

Parenti wrote that accounts of political repression are exaggerated by anti-communists and that communist party rule provided some human rights such as economic, social, and cultural rights not found under capitalist states, including the rights that everyone is treated equal regardless of education or financial stability; that any citizen can keep a job; or that there is a more efficient and equal distribution of resources. David L. Hoffmann stated that many forms of state interventionism used by Marxist–Leninist governments, including social cataloging, surveillance and internment camps, pre-dated the Soviet regime and originated outside Russia. Hoffman further stated that technologies of social intervention developed together with the work of 19th-century European reformers and were greatly expanded during World War I, when state actors in all the combatant countries dramatically increased efforts to mobilise and control their populations. As the Soviet state was born at this moment of total war, it institutionalised state intervention as permanent features of governance.

=== Biomarker of Turner syndrome === Turner syndrome is the most common sex chromosome-related inherited diseases in females around the world, with the incidence of 1 in 2000 live female births. One of the significant pathological features is the premature ovarian failure, leading to amenorrhea or even infertility. Follicle stimulating hormone and inhibin B were recommended to be monitored routinely by specialists to speculate the condition of ovary. Recently, anti-Müllerian hormone is advised as a more accurate biomarker for follicular development by several researchers. The biological function of anti-Müllerian hormone in ovary is to counteract the recruitment of primordial follicles triggered by FSH, reserving the follicle pool for further recruitment and ovulation. When menopause takes place, the serum concentration of anti-Müllerian hormone will be nearly undetectable among normal women. Thus, variations in AMH levels during childhood may theoretically predict the duration of any given girl's reproductive life span, assuming that the speed of the continuous follicle loss is comparable between individuals.

Sources: en.wikipedia.org

Further detail

The drug was found to have 392-fold higher potency at the mTAAR1 compared to the hTAAR1 in vitro in one comparative study, although it still activated the hTAAR1 with low-nanomolar potency (EC50 = 0.12 ).

is the number of constituent antiquarks. Beta decay just changes neutron to proton or, in the case of positive beta decay (electron capture) proton to neutron so the number of individual quarks doesn't change. It is only the baryon flavor that changes, here labelled as the isospin. Up and down quarks have total isospin

Too bad the story is so mindnumbingly dense." Fellow trade magazine The Hollywood Reporter called it a "half-baked action thriller" but still deemed it "enjoyable." Owen Gleiberman of Entertainment Weekly deemed that "the routinely scripted but kinetic Stone Cold is a throwback to Roger Corman's Hell's Angels flicks." He praised Henriksen and Forsythe for elevating the material, writing: "When they're on-screen, [the film] doesn't feel quite as B-movie-ish." Michael Wilmington of the Los Angeles Times accepted that "[t]he movie, full of unrelenting sadism, sleazy posturing and ludicrous dialogue—and some nice cinematography by Alexander Gruszynski—is far from boring." However he saw it as the ultimate example of "action movies [which] have begun to seem an end in themselves [...] as if nothing mattered any more but the sheer logistics of reducing some location to fiery chaos and rubble." Chris Hicks of Utah's Deseret News was put off by the film's violence, calling it "the bottom of the barrel" and Bosworth "a boorish clown on the field and even more boorish and clownish in his movie debut". In her nationally syndicated San Jose Mercury News review, Annette John-Hall found that "Stone Cold is a taylor-made vehicle for Bosworth, but the unpredictability and zaniness that made 'the Boz' a household name as a football player is lacking for Boz, the actor." In the city that Bosworth once called home, Steve Kelley of The Seattle Times urged: "Don’t fall for the Bosworth pitch.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine approved for human use?

No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.

Why is cardarine banned in sport?

It is prohibited by the World Anti-Doping Agency as a hormone and metabolic modulator. Athletes who test positive for GW501516 can face sanctions, including suspensions and loss of results.

What is the difference between cardarine and GW501516?

Cardarine is a common or trade-style name, while GW501516 is the research code for the same chemical entity. Some sources also use Endurobol or GSK-516. The names refer to the same compound, not distinct drugs.

What did animal studies show?

Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.

Network